Top Markets
Coin of the day
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
株式のランク #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
株価
$64.97
最終同期: 2024-05-20
時価総額
$1.97B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Alpine Immune Sciences, Inc. (ALPN)

カテゴリー

Alpine Immune Sciences, Inc.(ALPN)の株式分割履歴
Alpine Immune Sciences, Inc.株(シンボル:ALPN)は合計で1回の株式分割を実施しました。
最新の株式分割はJul 25, 2017に行われました。
Jul 25, 2017より前に購入されたALPN株は、現在0.25ALPN株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2017-07-25 1:4 x0.25 x0.25
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH